Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Tsitologiia ; 38(12): 955-63, 2016.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30188621

RESUMO

We have studied the dependence of cell viability on cell autophagy in control and senescent E1A+cHa-Ras transformed rat embryo fibroblasts. pp242, a TORC1/C2 kinase inhibitor, was used as a trigger of cell autophagy. Cell senescence was induced in the cells by sodium butyrate. pp242 inhibitor occurred to dramatically reduce the functional activity of mitochondria in intact cells causing their death by mitophagy and apoptosis. The presence of chloroquine that blocks lysosome and autophagosome fusion does not cancel pp242 effects. Senescent cells were more resistant to pp242 than control ones. However, their viability was significantly reduced in the presence of chloroquine and pp242. Thus, our results allow us to consider that the usage of chloroquine and pp242 combination is an effective way of cell death induction in intact and senescent Ras-transformants.

2.
Tsitologiia ; 58(12): 955-63, 2016.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30188618

RESUMO

We have studied the dependence of cell viability on cell autophagy in control and senescent E1A+cHa-Ras transformed rat embryo fibroblasts. pp242, a TORC1/C2 kinase inhibitor, was used as a trigger of cell autophagy. Cell senescence was induced in the cells by sodium butyrate. pp242 inhibitor occurred to dramatically reduce the functional activity of mitochondria in intact cells causing their death by mitophagy and apoptosis. The presence of chloroquine that blocks lysosome and autophagosome fusion does not cancel pp242 effects. Senescent cells were more resistant to pp242 than control ones. However, their viability was significantly reduced in the presence of chloroquine and pp242. Thus, our results allow us to consider that the usage of chloroquine and pp242 combination is an effective way of cell death induction in intact and senescent Ras-transformants.


Assuntos
Cloroquina/farmacologia , Indóis/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Purinas/farmacologia , Serina-Treonina Quinases TOR/antagonistas & inibidores , Animais , Morte Celular/efeitos dos fármacos , Morte Celular/genética , Linhagem Celular Transformada , Proteína p300 Associada a E1A/genética , Proteína p300 Associada a E1A/metabolismo , Genes ras , Ratos , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo
3.
Tsitologiia ; 58(12): 947-54, 2016.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30188620

RESUMO

Autophagy is a conservative process of misfolded protein and damaged organelle degradation that serves to support cellular viability. Autophagy is often induced in response to stress, DNA damage, retinoids, starvation and growth factor withdrawal. The aim of the present work was to study autophagic response of E1A+cHa-Ras-transformed cells to irradiation and to analyze the role of MEK/ERK pathway in regulation of autophagy induced by irradiation. MEK/ERK suppression has been found to decrease the viability of irradiated cells. Inhibition of MEK/ERK pathway leads to the changes in the autophagy induced by irradiation connected with disturbances of final stages followed by accumulation of adaptor protein p62/SQSTM1 in autophagic cavities within cytoplasm. Thus, the data obtained allow to suggest that active MEK/ERK pathway is required to support, the cytoprotective autophagy which is induced in response to irradiation of transformed E1A+cHa-ras cells.


Assuntos
Autofagia/efeitos da radiação , Citoproteção , Sistema de Sinalização das MAP Quinases/efeitos da radiação , Raios X/efeitos adversos , Animais , Autofagia/genética , Linhagem Celular Transformada , Proteína p300 Associada a E1A/genética , Proteína p300 Associada a E1A/metabolismo , Genes ras , Sistema de Sinalização das MAP Quinases/genética , Ratos , Proteína Sequestossoma-1/genética , Proteína Sequestossoma-1/metabolismo
4.
Tsitologiia ; 57(2): 135-43, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26035971

RESUMO

We have investigated the role of apoptosis resistance gene bcl-2 in the activation of cellular senescence program induced by histone deacetylase inhibitor (HDACi) sodium butyrate (NaBut) in transformed rat fibroblasts. This study was conducted in a resistant to apoptosis induction cell line of rat embryo fibroblasts transfor- med by oncogenes E1A, cHa-ras and bcl-2 (ERasBcl). The parent cell line transformed with only EJA and cHa-ras (ERas) was used as a control. It has been found that NaBut reduces proliferation rate of ERasBcl cells significantly weaker than of ERas transformed cells, despite the fact that the G1 cell cycle arrest was observed in both cell lines. After NaBut treatment, hypertrophy of the apoptosis resistant transformants ERasBcl also was reduced compared to parent cell line ERas, due to less activation of mTORC1, which is known to control the synthesis of protein and ribosome biogenesis. The degree of mTORC1 activation was as.sessed by its target proteins phosphorylation: the ribosomal S6 protein and 4E-BP1--inhibitor of translation initiation factor eIF4E. Since cell senescence process may be associated with changes in autophagy regulation, we analyzed the dynamics of one of the main autophagosome formation markers--protein LC3. The accumulation of lipid-bound form LC3-II changes significantly in ERasBcl cells after NaBut treatment and has transient nature. The set of analyzed cellular senescence markers suggests that a high level of apoptosis resistance gene bcl-2 expression prevents the realization of tumor-suppressor senescence program induced by HDACi sodium butyrate treatment.


Assuntos
Senescência Celular/genética , Ciclina A/genética , Genes ras/genética , Proteínas Proto-Oncogênicas c-bcl-2/genética , Animais , Apoptose/efeitos dos fármacos , Apoptose/genética , Autofagia/genética , Ácido Butírico/administração & dosagem , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/genética , Senescência Celular/efeitos dos fármacos , Ciclina A/biossíntese , Fibroblastos/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Inibidores de Histona Desacetilases/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Ratos
5.
Tsitologiia ; 57(11): 755-60, 2015.
Artigo em Russo | MEDLINE | ID: mdl-27012089

RESUMO

Macrophage is a key cell of immune system, it participates in antiviral, antimicrobial and antitumor defense of the organism, also in regeneration and reparation of tissues. Macrophage coordinates functioning of immune system, participates in tumor growth progression. The process of inflammation consists of two stages. Cytotoxical potential of immunocompetent cells will be realized in the first stage, to avoid a bacterial infection. The second stage of inflammatory process is associated with reparation and regeneration. During inflammation, according it stages, macrophages change functional state, switching from cytotoxical M1 to M2, that associated with reparation. We suppose, that rapamysin, a suppressor of mTOR, causes completely different effects on tumor associated macrophages and cells of microglia. Rapamycin transforms tissue macrophages into M1 phenotype, promoting the tumor regression. While in microglial cells of the central nervous system it induces transformation into M2 phenotype, facilitating the course of the neurodegenerative disease and slowing down the aging.


Assuntos
Infecções Bacterianas/imunologia , Macrófagos/imunologia , Neoplasias/imunologia , Doenças Neurodegenerativas/imunologia , Transdução de Sinais/imunologia , Serina-Treonina Quinases TOR/imunologia , Viroses/imunologia , Animais , Infecções Bacterianas/patologia , Humanos , Macrófagos/patologia , Neoplasias/patologia , Doenças Neurodegenerativas/mortalidade , Transdução de Sinais/efeitos dos fármacos , Sirolimo/farmacologia , Serina-Treonina Quinases TOR/antagonistas & inibidores , Viroses/patologia
6.
Tsitologiia ; 56(8): 581-90, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25697003

RESUMO

A key regulator of cellular senescence, mTORC1 complex, is the target of many signaling cascades including Ras/Raf/MEK/ERK-signaling cascade. In this paper we investigated the role of MEK/ERK-branch of this cascade in the process of cellular senescence induced by histone deacetylase inhibitor (HDACI) sodium butyrate (NaBut), in transformed rat embryo fibroblasts. Suppression of MEK/ERK activity by inhibitor PD0325901 does not prevent activation of mTORC1 complex induced by NaBut treatment. After the suppression of MEK/ERK, activity of mTORC1 increased as well as complex mTORC2. Activation of mTOR-containing complexes accompanied by the reorganization of the actin cytoskeleton with the formation of actin stress fibers and the appearance of some markers of cellular senescence. In contrast to NaBut-induced senescence accumulation of proteins was not observed, which may be due to increased activity of the degradation processes. Furthermore, the induction of senescence in conditions suppressed MEK/ERK leads to a drastic decrease in cell viability. Thus, NaBut-induced senescence upon suppressed activity of MEK/ERK-branch of MAP kinase cascade has a more pronounced tumor-suppressor effect associated with stronger activation of both mTOR-complexes, reorganization of the actin cytoskeleton and protein degradation.


Assuntos
Senescência Celular/genética , Fibroblastos/metabolismo , Histona Desacetilase 1/genética , Proteína Quinase 1 Ativada por Mitógeno/genética , Proteína Quinase 3 Ativada por Mitógeno/genética , Citoesqueleto de Actina/efeitos dos fármacos , Citoesqueleto de Actina/ultraestrutura , Animais , Benzamidas/farmacologia , Ácido Butírico/farmacologia , Linhagem Celular Transformada , Sobrevivência Celular/efeitos dos fármacos , Senescência Celular/efeitos dos fármacos , Difenilamina/análogos & derivados , Difenilamina/farmacologia , Embrião de Mamíferos , Fibroblastos/efeitos dos fármacos , Fibroblastos/ultraestrutura , Regulação da Expressão Gênica , Histona Desacetilase 1/antagonistas & inibidores , Histona Desacetilase 1/metabolismo , Inibidores de Histona Desacetilases/farmacologia , Alvo Mecanístico do Complexo 1 de Rapamicina , Alvo Mecanístico do Complexo 2 de Rapamicina , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Complexos Multiproteicos/genética , Complexos Multiproteicos/metabolismo , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Proto-Oncogênicas p21(ras)/genética , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Ratos , Transdução de Sinais , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo
7.
Tsitologiia ; 54(8): 589-602, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23074850

RESUMO

Kinase TOR (target of rapamycin), discovered as a target of antibiotic rapamycin, the evolutionarily conservative serine/threonine kinase that integrates numerous extra-cellular and intracellular signals, regulating cell growth, protein synthesis and metabolism. Mammalian kinase (mTOR) exists in two complexes: the rapamycin-sensitive TORC1 and rapamycin resistant mTORC2, controlling in the cell different programs. Identification of mTOR as integral component PI3/Akt way that deregulated during carcinogenesis, as well as the existence of a cross-talk between the tumor-suppressor p53 cascade and mTOR demonstrates its unique role in the process of neoplastic growth. This review discusses the various aspects of the regulation of the kinase mTOR, the relationship with the general cell-signaling pathways and its use as a target for the cancer, diabetes, obesity, neurodegenerative changes and hereditary syndromes of aging.


Assuntos
Transformação Celular Neoplásica/metabolismo , Neoplasias/metabolismo , Transdução de Sinais , Serina-Treonina Quinases TOR/metabolismo , Animais , Proliferação de Células , Transformação Celular Neoplásica/genética , Humanos , Longevidade/genética , MAP Quinase Quinase 4/genética , MAP Quinase Quinase 4/metabolismo , Camundongos , Neoplasias/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Serina-Treonina Quinases TOR/genética , Proteína Supressora de Tumor p53/metabolismo
8.
Tsitologiia ; 54(12): 902-10, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23461035

RESUMO

We studied the role of p38 kinase and JNK1,2 in the activation of the complex mTORC1 and the program of senescence induced by histone deacetylase inhibitor, sodium butyrate (NaBut), in mouse embryonic fibroblasts transformed by E1A+cHa-Ras oncogenes. It was found that transformants from knockouts for the genes p38, were able to implement the program of NaBut-induced senescence, according to the data of the cell cycle arrest, inhibition of proliferation, hypertrophic changes associated with the activation of mTORC1 and SA-beta-galactosidase activity. According to the behavior of these markers, cell knockouts for the genes jnk1,2 were unable to implement NaBut-induced senescence. Induction of senescence closely correlates with the activation of the complex mTORC1, as it was shown by inhibiting mTORC1 with rapamycin. We believe that JNK 1,2 kinases are required for mTORC1 activation and acquiring the markers of premature senescence, induced by NaBut in the E1A+cHa-Ras transformants.


Assuntos
Senescência Celular , Sistema de Sinalização das MAP Quinases , Complexos Multiproteicos , Serina-Treonina Quinases TOR , Proteínas Quinases p38 Ativadas por Mitógeno , Animais , Butiratos/farmacologia , Proliferação de Células , Senescência Celular/efeitos dos fármacos , Senescência Celular/genética , Fibroblastos , Inibidores de Histona Desacetilases , Sistema de Sinalização das MAP Quinases/genética , Alvo Mecanístico do Complexo 1 de Rapamicina , Camundongos , Complexos Multiproteicos/metabolismo , Fosforilação , Sódio/farmacologia , Serina-Treonina Quinases TOR/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/genética , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
9.
Cell Cycle ; 9(19): 3945-55, 2010 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-20935470

RESUMO

Cell senescence is characterized by senescent morphology and permanent loss of proliferative potential. HDAC inhibitors (HDACI) induce senescence and/or apoptosis in many types of tumor cells. Here, we studied the role of cyclin-kinase inhibitor p21(waf1) (Cdkn1n gene) in cell cycle arrest, senescence markers (cell hypertrophy, SA-ßGal staining and accumulation of γH2AX foci) in p21(Waf1+/+) versus p21(Waf1-/-) mouse embryonic fibroblast cells transformed with E1A and cHa-Ras oncogenes (mERas). While short treatment with the HDACI sodium butyrate (NaB) induced a reversible G(1) cell cycle arrest in both parental and p21(Waf1-/-) cells, long-term treatment led to dramatic changes in p21(Waf1+/+) cells only: cell cycle arrest became irreversible and cells become hypertrophic, SA-ßGal-positive and accumulated γH2AX foci associated with mTORC1 activation. The p21(Waf1+/+) cells lost their ability to migrate into the wound and through a porous membrane. Suppression of migration was accompanied by accumulation of vinculin-staining focal adhesions and Ser3-phosphorylation of cofilin, incapable for F-actin depolymerization. In contrast, the knockout of the p21(Waf1) abolished most of the features of NaB-induced senescence, including irreversibility of cell cycle arrest, hypertrophy, additional focal adhesions and block of migration, γH2AX foci accumulation and SA-ßGal staining. Rapamycin, a specific inhibitor of mTORC1 kinase, decreased cellular hypertrophy, canceled coffilin phosphorylation and partially restored cell migration in p21(Waf1+/+) cells. Taken together, our data indicate a new role of p21(Waf1) in cell senescence, which may be connected not only with execution of cell cycle arrest, but also with the development of mTOR-dependent markers of cellular senescence.


Assuntos
Butiratos/farmacologia , Ciclo Celular/efeitos dos fármacos , Senescência Celular/fisiologia , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , Inibidores de Histona Desacetilases/farmacologia , Animais , Biomarcadores/metabolismo , Linhagem Celular , Células Cultivadas , Inibidor de Quinase Dependente de Ciclina p21/genética , Fibroblastos/citologia , Fibroblastos/fisiologia , Camundongos , Camundongos Knockout , Proteína Oncogênica p21(ras)/genética , Proteína Oncogênica p21(ras)/metabolismo , Serina-Treonina Quinases TOR/metabolismo
10.
Tsitologiia ; 50(11): 964-71, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19140343

RESUMO

We studied the role of JNK1,2 stress-kinases in the regulation of premature senescence program, stimulated by the inhibitor of histone deacetylase, sodium butyrate (NaB). It was found, that the transformants EIA + cHa-ras selected from embryonic mouse fibroblasts with knockout jnk1,2 stress-kinase genes did not block the cell cycle after sodium butyrate treatment. The data on the cell cycle distribution and cell growth curves showed that even long term (during five days) NaB influence did not suppress proliferation. We did not also reveal any cellular hypertrophy and increase in SA-beta-galactosidase activity after NaB treatment. The data presented suggest that JNK stress-kinases are involved in sodium butyrate-induced senescence in E1A + cHa-Ras mouse transformants, and they are indicative of that JNK1,2 have tumor suppressor properties.


Assuntos
Senescência Celular/fisiologia , Proteína Quinase 8 Ativada por Mitógeno/fisiologia , Proteína Quinase 9 Ativada por Mitógeno/fisiologia , Animais , Butiratos/farmacologia , Linhagem Celular Transformada , Proliferação de Células , Proteína p300 Associada a E1A/genética , Proteína p300 Associada a E1A/metabolismo , Embrião de Mamíferos , Fibroblastos/efeitos dos fármacos , Genes ras/genética , Inibidores de Histona Desacetilases , Histona Desacetilases/farmacologia , Camundongos , Camundongos Knockout , Proteína Quinase 8 Ativada por Mitógeno/genética , Proteína Quinase 9 Ativada por Mitógeno/genética , Transformação Genética , beta-Galactosidase/metabolismo
11.
Tsitologiia ; 49(2): 115-24, 2007.
Artigo em Russo | MEDLINE | ID: mdl-17432596

RESUMO

We investigated the role of p38alpha stress-kinase in regulation of premature senescence program, stimulated by histone deacetylase inhibitor--sodium butyrate (NaB)--after application to rodent transformed cell lines. Investigation was performed on the E1A + cHa-ras transformants selected from mice embryonic fibroblasts null at the p38alpha kinase gene or null fibroblasts at the PPM1D gene, which encoded phosphatase Wip1. Absence of Wip1 led to constitutive activation of p38alpha kinase. It was revealed that after NaB treatment both cell lines completely stopped proliferation due to irreversible cell cycle arrest in G1/S phase. In both cell lines sodium butyrate induced sustained block of prolifaration due to irreversible cell cycle arrest in G1/S phase. Following sodium butyrate treatment cells expressed marker of senescence--beta-galactosidase activity (SA-beta-Gal). Long-term (during several days) NaB treatment of cells led to partial restoration of actin cytoskeleton, focal adhesion contacts and heterochromatin focus formation (SAHF) in the nucleus of senescent cells. Obtained data allow us to suppose that irreversible process of cellular senescence activated by sodium butyrate can occur in the absence of functionally active p38 kinase by means of other ways of cell cycle suppression.


Assuntos
Senescência Celular/fisiologia , Proteína Quinase 14 Ativada por Mitógeno/fisiologia , Animais , Butiratos/farmacologia , Ciclo Celular/efeitos dos fármacos , Proliferação de Células , Células Cultivadas , Proteína p300 Associada a E1A/genética , Proteína p300 Associada a E1A/metabolismo , Embrião de Mamíferos , Fibroblastos/fisiologia , Deleção de Genes , Genes ras/genética , Inibidores de Histona Desacetilases , Camundongos , Proteína Quinase 14 Ativada por Mitógeno/deficiência , Proteína Quinase 14 Ativada por Mitógeno/genética , Proteínas de Neoplasias/deficiência , Proteínas de Neoplasias/genética , Fosfoproteínas Fosfatases/deficiência , Fosfoproteínas Fosfatases/genética , Proteína Fosfatase 2C , Transformação Genética , beta-Galactosidase/metabolismo
12.
Tsitologiia ; 47(12): 1055-62, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16706193

RESUMO

We investigated a possibility to induce the premature cell senescence in rat embryo fibroblasts and E1A + cHa-ras transformants. We found that after the treatment with sodium butyrate, an inhibitor of histone deacetylases, both normal and transformed cells completely stopped to proliferate and accumulated at G1/S and G2/M phases of the cell cycle. The cloning efficiency data show that the cell cycle arrest induced by sodium butyrate is irreversible and correlates with the accumulation of active phosphorylated form of stress kinase p38, and with the expression of marker of senescence--beta-galactosidase activity (SA beta-Gal). The program resembling the premature senescence after sodium butyrate treatment is supposed to develop both in normal and transformed cells. The irreversible block of proliferation in E1A + cHa-ras transformants may be regarded as an example of activation of anticancer program like that of premature senescence in the tumor rodent cells.


Assuntos
Butiratos/farmacologia , Senescência Celular/efeitos dos fármacos , Inibidores de Histona Desacetilases , Animais , Biomarcadores/metabolismo , Ciclo Celular , Linhagem Celular Transformada , Linhagem Celular Tumoral , Células Cultivadas , Embrião de Mamíferos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/fisiologia , Ratos , Sódio/farmacologia , Fatores de Tempo , beta-Galactosidase/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
13.
Tsitologiia ; 47(10): 907-16, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16711390

RESUMO

Introduction of bcl-2 gene in EIA + c-Ha-ras-transformed rat embryo fibroblasts, which are unable to be arrested after damaging influences and possess high proapoptotic sensitivity, results not only in suppression of cell death but also in re-establishment of cell cycle block following DNA damage and serum starvation. Flow cytometry showed that E1A + c-Ha-ras + bcl-2-transformants treated with DNA-intercalator adriamycin are capable of being arrested at G1/S boundary for a long time (for less than 5 days). According to the growth curve data, the number of Bcl-2-overexpressing cells remanins constant for a week of cultivation with adriamycin. Clonogenic efficacy of E1A + c-Ha-ras + bcl-2-cells is brought to no already in 16 h after adriamycin addition. Apoptotic death, revealed by oligonucleosomic fragmentation of DNA, as well as cell death, occurring due to mitotic catastrophe, after adriamycin treatment are almost absent in Bcl-2-overexpressing transformants, as compared with parental E1A + c-Ha-ras-transformants. Bcl-2 introduction in E1A + c-Ha-ras-transformants is accompanied by a rise of SA beta-Gal (Senescence Associated beta-Galactosidase) activity, which is commonly considered to be a marker of cell senescence. Adriamycin treatment of E1A + c-Ha-ras + bcl-2-transformants results in a much higher rise in SA beta-Gal activity, as compared with untreated cells. Co-immunoprecipitation experiments demonstrated the introduction of Bcl-2 to result in formation of Bcl-2 complexes with early region E1A oncoproducts, which are thought to be responsible for proapoptotic susceptibility of E1A-expressing transformants. The data obtained lead to suggestion that bcl-2 transfer to E1A + c-Ha-ras-transformants may induce a switch from the cell death program on the program of senescence after DNA damage, due, presumably, to Bcl-2 interaction with the apoptosis activator the viral oncoprotein E1A.


Assuntos
Proteínas E1A de Adenovirus/genética , Apoptose/efeitos dos fármacos , Senescência Celular/efeitos dos fármacos , Doxorrubicina/farmacologia , Substâncias Intercalantes/farmacologia , Proto-Oncogenes , Animais , Apoptose/genética , Linhagem Celular Transformada , Senescência Celular/genética , Clonagem Molecular , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Citometria de Fluxo , Genes bcl-2 , Genes ras , Humanos , Ratos , beta-Galactosidase/metabolismo
15.
Vopr Onkol ; 46(2): 199-201, 2000.
Artigo em Russo | MEDLINE | ID: mdl-10853421

RESUMO

mdr-Transfected K-562 cells revealed a relatively high resistance to cytotoxic monokines and ionizing radiation as compared to parental cells. Taken together with what is known about the resistance of mdr-expressing cells to multiple cytotoxic drugs, our results point to malignant cells having universal mechanisms of chemo-, bio- and radioresistance.


Assuntos
Genes MDR , Células K562/efeitos dos fármacos , Células K562/efeitos da radiação , Monocinas/metabolismo , Divisão Celular/efeitos dos fármacos , Divisão Celular/efeitos da radiação , Raios gama , Humanos , Células K562/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/efeitos da radiação , Radiação Ionizante , Radioterapia/métodos , Transfecção
17.
Vopr Onkol ; 45(6): 645-9, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10703514

RESUMO

It was shown that in vitro irradiation (8 Gy) of murine peritoneal macrophages suppressed their spontaneous cytotoxity and induced growth-stimulating activity. Exposure to 4 Gy induced mRNA proximal factors--TGF-beta and TNF-alpha and boosted growth-stimulating activity. These effects should be considered when evaluating efficacy of radiotherapy for tumors.


Assuntos
Macrófagos Peritoneais/metabolismo , Macrófagos Peritoneais/efeitos da radiação , Animais , Camundongos , Camundongos Endogâmicos BALB C , RNA Mensageiro/efeitos da radiação , Doses de Radiação , Radiação Ionizante , Fator de Crescimento Transformador beta/efeitos da radiação , Fator de Necrose Tumoral alfa/efeitos da radiação
19.
Tsitologiia ; 39(8): 694-8, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9490507

RESUMO

Murine peritoneal macrophages, activated by BCG vaccine, and human peripheral blood monocytes, activated by lipopolysaccharides, exerted neurite stimulating or neurite inhibiting effects in various periods of activation. The supernatants of these preparations were active in organotypic culture of chick embryo dorsal root ganglia. The inhibition of neurite growth on the 1st day of cultivation was followed by the neurite-stimulating effect. The fluctuation of neurite-inhibition and neurite-stimulation effect of macrophage supernatants suggest the availability of certain changes in cytokine composition in different periods of macrophage activation.


Assuntos
Axônios/efeitos dos fármacos , Gânglios Sensitivos/efeitos dos fármacos , Fatores Ativadores de Macrófagos/farmacologia , Animais , Axônios/ultraestrutura , Vacina BCG/farmacologia , Divisão Celular/efeitos dos fármacos , Embrião de Galinha , Técnicas de Cultura , Gânglios Sensitivos/ultraestrutura , Humanos , Lipopolissacarídeos/farmacologia , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Monócitos/efeitos dos fármacos , Monócitos/imunologia , Fatores de Tempo
20.
Vopr Onkol ; 42(5): 80-5, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9064911

RESUMO

It has been established that once macrophages become activated, they pass through different stages of functional activity. Mouse macrophages activated by BCG "exerted" pronounced cytotoxic effects for 2-5 days to be followed later by growth-stimulating ones. However, in other experiments, the cytotoxic effect was either absent or occurred at later stages which was probably due to a certain functional state of macrophages before activation. The synthesis of TGF-beta increased 1-2 days after activation with BCG vaccine, lipopolysacharide and gamma radiation. An increase in mRNA TGF-beta i expression was observed only 5 days after activation of macrophages.


Assuntos
Macrófagos/metabolismo , Fator de Crescimento Transformador beta/biossíntese , Animais , Raios gama , Lipopolissacarídeos , Ativação de Macrófagos , Camundongos , Mycobacterium bovis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...